Fiserv Inc. Common Stock vs Oruka Therapeutics Inc. Common Stock — how do they compare? Fiserv Inc. Common Stock trades at $46.29 (market cap $24.81B), while Oruka Therapeutics Inc. Common Stock trades at $75.2 (market cap $5.18B). The key difference: Fiserv Inc. Common Stock is far larger — about 4.8× Oruka Therapeutics Inc. Common Stock's market cap, and Oruka Therapeutics Inc. Common Stock is trading nearer its 52-week high, Fiserv Inc. Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Fiserv Inc. Common Stock for 0 Days and Oruka Therapeutics Inc. Common Stock for 0 Days on average.
| FISV | ORKA | |
|---|---|---|
Market Cap | $24.81B | $5.18B |
Volume | 4,091,234 | 490,798 |
Sector | Technology | Health |
52-Week High | $126.54 | $113.08 |
52-Week Low | $44.36 | $26.19 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $52.60B | $4.31B |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Fiserv, Inc. is a global provider of payments and financial services technology, offering merchant acquiring, digital commerce, and financial solutions through its Merchant Solutions and Financial Solutions segments.
Read more on FISV →Oruka Therapeutics, Inc. is a clinical-stage biotechnology company developing extended half-life monoclonal antibodies for plaque psoriasis, psoriatic arthritis, and related dermatologic conditions, with lead candidates ORKA-001 and ORKA-002 in clinical trials.
Read more on ORKA →